Nuscience medical Products

NeoThelium is an amniotic membrane allograft derived from a prescreened mother with a planned delivery. NeoThelium is manufactured in compliance with FDA regulations. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. NeoThelium FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.